Binuclear ruthenium complexes inhibit the fibril formation of human islet amyloid polypeptide
نویسندگان
چکیده
The deposition of human islet amyloid polypeptide (hIAPP) is closely correlated with type II diabetesmellitus (T2DM). hIAPPmisfolding, as a significant causative factor of T2DM, can lead to the failure of islet transplant. Therefore, preventing the aggregation of hIAPP is one of the most vital factors to treat T2DM. Mononuclear Ru complexes have recently been proved to inhibit the aggregation of hIAPP. In the present work, the influences of three water-soluble binuclear Ru complexes, namely, Na2[{trans-RuCl4(DMSO)}2(m-pyz)] (1), Na2[{trans-RuCl4(DMSO)}2(m-pym)] (2), and Na2[{trans-RuCl4(DMSO)}2(m-bipy)] (3), on hIAPP fibril formation with mononuclear compounds were determined and compared. Results indicated that the three binuclear Ru complexes effectively inhibited the fibrillation of hIAPP to form nanoscale particles and decreased the b-sheet component of peptides, thus reducing the cytotoxicity induced by hIAPP. Binuclear Ru complexes showed better inhibition ability than their corresponding mononuclear Ru complexes, which might be attributed to the second metal center. Our study provided new insights into the design of multinuclear Ru complexes as potential metallodrugs against T2DM.
منابع مشابه
Inhibition of human amylin fibril formation by insulin-mimetic vanadium complexes.
The toxicity of amyloid-forming proteins can be linked to many degenerative and systemic diseases. Human islet amyloid polypeptide (hIAPP, amylin) has been associated with type II diabetes. Methods for efficient inhibition of amyloid fibril formation are highly clinically important. This study demonstrated the significant inhibitory effects of six vanadium complexes on hIAPP aggregation. Vanadi...
متن کاملDefining the Molecular Basis of Amyloid Inhibitors: Human Islet Amyloid Polypeptide–Insulin Interactions
Human islet amyloid polypeptide (hIAPP or Amylin) is a 37 residue hormone that is cosecreted with insulin from the pancreatic islets. The aggregation of hIAPP plays a role in the progression of type 2 diabetes and contributes to the failure of islet cell grafts. Despite considerable effort, little is known about the mode of action of IAPP amyloid inhibitors, and this has limited rational drug d...
متن کاملAspirin, Diabetes, and Amyloid: Re-examination of the Inhibition of Amyloid Formation by Aspirin and Ketoprofen
The loss of β-cell function and β-cell death are key features of diabetes. A range of mechanisms are thought to contribute to β-cell loss, including islet amyloid formation by the neuropancreatic hormone amylin (islet amyloid polypeptide, IAPP). Islet amyloid deposition also contributes to the failure of islet transplants. There are no therapeutic strategies for the treatment or prevention of i...
متن کاملGeneral Amyloid Inhibitors? A Critical Examination of the Inhibition of IAPP Amyloid Formation by Inositol Stereoisomers
Islet amyloid polypeptide (IAPP or amylin) forms amyloid deposits in the islets of Langerhans; a process that is believed to contribute to the progression of type 2 diabetes and to the failure of islet transplants. An emerging theme in amyloid research is the hypothesis that the toxic species produced during amyloid formation by different polypeptides share common features and exert their effec...
متن کاملDiagnostic and therapeutic potential of amyloid-reactive IgG antibodies contained in human sera.
Passive immunotherapy using fibril-reactive mAbs has been shown experimentally to reduce amyloid formation and also accelerate amyloidolysis. We now report that human sera, as well as various sources of pooled human IgG, including pharmacologic formulations of immune globulin i.v. (IGIV), contain Abs that specifically recognize fibrils formed from light chains and other amyloidogenic precursor ...
متن کامل